| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
62,460 |
55,262 |
$2.18M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,406 |
20,444 |
$1.17M |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
5,730 |
5,139 |
$793K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,985 |
13,420 |
$741K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
18,743 |
16,662 |
$698K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,405 |
9,614 |
$670K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,956 |
7,246 |
$498K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,640 |
6,777 |
$444K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,109 |
5,250 |
$407K |
| 95117 |
|
43,740 |
20,530 |
$400K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
3,708 |
2,992 |
$356K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,448 |
2,856 |
$233K |
| 92587 |
|
5,204 |
4,601 |
$224K |
| 94375 |
|
5,381 |
4,397 |
$105K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,842 |
7,332 |
$102K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,224 |
3,540 |
$95K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,140 |
948 |
$91K |
| 95024 |
|
1,363 |
1,100 |
$85K |
| 99173 |
|
10,489 |
9,195 |
$85K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
6,003 |
4,977 |
$84K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
668 |
621 |
$83K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,280 |
2,868 |
$74K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,917 |
7,688 |
$72K |
| 96161 |
|
3,146 |
2,208 |
$61K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,482 |
2,940 |
$57K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,369 |
4,676 |
$51K |
| 99174 |
|
4,855 |
4,487 |
$45K |
| 90677 |
|
551 |
434 |
$32K |
| 95115 |
|
3,733 |
1,930 |
$27K |
| 96160 |
|
2,207 |
1,642 |
$26K |
| 81003 |
|
10,655 |
9,081 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
422 |
364 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
696 |
674 |
$21K |
| 96127 |
|
4,150 |
3,518 |
$16K |
| 90670 |
|
4,683 |
4,001 |
$14K |
| 92551 |
|
1,742 |
1,453 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
4,414 |
3,616 |
$10K |
| 0240U |
|
73 |
71 |
$9K |
| 83655 |
|
575 |
518 |
$9K |
| 36416 |
|
2,931 |
2,590 |
$8K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
476 |
225 |
$7K |
| 90698 |
|
3,481 |
2,867 |
$6K |
| 95012 |
|
1,744 |
1,342 |
$6K |
| 94060 |
|
177 |
138 |
$6K |
| 98966 |
|
212 |
94 |
$6K |
| 90461 |
|
8,810 |
7,405 |
$5K |
| 90656 |
|
314 |
216 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
80 |
77 |
$4K |
| 90680 |
|
2,336 |
1,859 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
177 |
160 |
$4K |
| 90619 |
|
70 |
41 |
$4K |
| 90474 |
|
468 |
366 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
70 |
63 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
80 |
75 |
$3K |
| 90651 |
|
284 |
216 |
$3K |
| 90688 |
|
2,061 |
1,874 |
$3K |
| 99384 |
|
35 |
25 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
46 |
41 |
$2K |
| 90686 |
|
2,308 |
1,997 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
66 |
38 |
$2K |
| 90716 |
|
581 |
533 |
$1K |
| 90700 |
|
3,139 |
2,784 |
$1K |
| 99383 |
|
13 |
12 |
$1K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
17 |
13 |
$1K |
| 90707 |
|
587 |
546 |
$976.18 |
| 90713 |
|
1,777 |
1,550 |
$932.50 |
| 90633 |
|
961 |
883 |
$931.72 |
| 90473 |
|
100 |
90 |
$823.13 |
| 90734 |
|
125 |
105 |
$818.60 |
| 90744 |
|
1,299 |
986 |
$701.51 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
18 |
17 |
$643.04 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
15 |
$637.64 |
| 87428 |
|
12 |
12 |
$635.90 |
| 99460 |
|
12 |
12 |
$562.07 |
| 92558 |
|
77 |
60 |
$535.21 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
18 |
16 |
$524.48 |
| 88720 |
|
119 |
60 |
$516.27 |
| 82962 |
|
569 |
433 |
$466.66 |
| 80061 |
Lipid panel |
68 |
49 |
$446.60 |
| 81025 |
|
85 |
63 |
$421.64 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
578 |
434 |
$265.17 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
32 |
24 |
$264.86 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
12 |
$262.78 |
| 90620 |
|
13 |
12 |
$259.78 |
| 95251 |
|
34 |
29 |
$222.25 |
| 90648 |
|
1,807 |
1,573 |
$216.37 |
| 99222 |
Initial hospital care, per day, moderate complexity |
12 |
12 |
$186.94 |
| 87807 |
|
13 |
12 |
$166.80 |
| 87420 |
|
258 |
200 |
$156.45 |
| 94760 |
|
2,089 |
1,628 |
$122.02 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
17 |
12 |
$114.58 |
| 92250 |
|
18 |
17 |
$108.27 |
| 91200 |
|
65 |
55 |
$99.05 |
| 90715 |
|
35 |
24 |
$54.64 |
| 87210 |
|
15 |
12 |
$46.71 |
| 84439 |
|
23 |
15 |
$44.88 |
| 90687 |
|
506 |
452 |
$43.34 |
| 90674 |
|
109 |
94 |
$36.87 |
| 76937 |
|
36 |
25 |
$35.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
132 |
129 |
$35.49 |
| 90672 |
|
43 |
41 |
$28.23 |
| 3008F |
|
23,248 |
20,488 |
$0.00 |
| 99070 |
|
52 |
44 |
$0.00 |
| 80050 |
General health panel |
18 |
14 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
19 |
17 |
$0.00 |
| 87081 |
|
39 |
39 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
21 |
13 |
$0.00 |
| 0500F |
|
78 |
71 |
$0.00 |
| 3044F |
|
21 |
13 |
$0.00 |
| 4274F |
|
332 |
241 |
$0.00 |
| 90685 |
|
68 |
66 |
$0.00 |
| 99001 |
|
883 |
498 |
$0.00 |
| 3078F |
|
20 |
13 |
$0.00 |
| 90710 |
|
13 |
12 |
$0.00 |
| 2028F |
|
38 |
29 |
$0.00 |
| 90661 |
|
14 |
13 |
$0.00 |